Epidemiology of invasive Streptococcus pyogenes infections in France in 2007

Journal of Clinical Microbiology

Volumn 49, Issue 12, 2011, Pages 4094-4100

  Lepoutre, A ^a   Doloy, A ^b,c,d   Bidet, P ^c,e   Leblond, A ^a   Perrocheau, A ^a   Bingen, E ^c,e   Trieu Cuot, P ^f   Bouvet, A ^b,c   Poyart, C ^b,c,d,f   Levy Bruhl D ^a  

^a French Institute for Public Health Surveillance   (France)

^b Institut Cochin   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; STEROID; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL SKIN DISEASE; BACTERIAL STRAIN; CHILD; CLINICAL FEATURE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EMM1 GENE; EMM28 GENE; EMM89 GENE; FATALITY; FEMALE; FRANCE; GENE SEQUENCE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PUERPERAL INFECTION; SOFT TISSUE INFECTION; TOXIC SHOCK SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; FASCIITIS, NECROTIZING; FEMALE; FRANCE; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; SEQUENCE ANALYSIS, DNA; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 82455186826     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00070-11     Document Type: Article

References (31)

1. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958. (Pubitemid 26091514)
2. Berger, F., P. Bernillon, and A, Gallay. 2010. Surveillance des infections invasives à méningocoque en France mé tropolitaine en 2005. Évaluation quantitative par la méthode de capture-recapture à trois sources. Institut de Veille Sanitaire, Saint-Maurice. France. http://www.invs.sante.fr/surveillance /iim/default.htm.
3. Berger, F., et al. 2007. Three-sources capture-recapture analysis to evaluate the comprehensiveness of reporting invasive meningococcal infections in France, poster 3. Abstr. 9th Meet. Eur. Monitoring Group Meningococci. http://www.invs.sante.fr/surveillance/iim/poster-emgm-rome.pdf.
4. Bisno, A. L., F. A. Rubin, P. P. Cleary, and J. B. Dale. 2005. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles-report of a National Institute of Allergy and Infectious Diseases workshop. Clin. Infect. Dis. 41:1150-1156. (Pubitemid 41429478)
5. Conseil Supérieur d'Hygiène Publique de France, Comité Technique des Infections Nosocomiales et des Infections Liées aux Soins. 2006. Guide pour la prévention et l'investigation des infections hospitalières à Streptococcus pyogenes. Ministère de la Santé, Paris, France.
6. Conseil Supérieur d'Hygiène Publique de France, Section des Maladies Transmissibles. 2005. Avis relatif à la conduite à tenir autour d'un ou de plusieurs cas, d'origine communautaire, d'infections invasives à Streptococcus pyogenes (ou streptocoques du groupe A) séance du 18 Novembre 2005. Ministère de la Santé, Paris, France.
7. Daneman, N., et al. 2005. Hospital-acquired invasive group A streptococcal infections in Ontario, Canada, 1992-2000. Clin. Infect. Dis. 41:334-342. (Pubitemid 41022110)
8. Darenberg, J., et al. 2007. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45:450-458. (Pubitemid 47204461)
9. Davies, H. D., et al. 1996. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N. Engl. J. Med. 335:547-554. (Pubitemid 26272309)
10. Goulet, V., et al. 2001. Effect of prevention measures on incidence of human listeriosis, France, 1987-1997. Emerg. Infect. Dis. 7:983-989. (Pubitemid 33115777)
11. Lamagni, T. L., et al. 2008. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 46:2359-2367.
12. Lamagni, T. L., et al. 2008. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg. Infect. Dis. 14:202-209.
13. Lamagni, T. L., et al. 2008. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin. Microbiol. Infect. 14:1002-1009. (Pubitemid 352748840)
14. Lepoutre, A., E. Varon, S. Georges, L. Gutmann, and D. Levy-Bruhl. 2008. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill. 13(35):pii=18962.
15. Luca-Harari, B., et al. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47:1155-1165.
16. Luca-Harari, B., et al. 2008. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J. Clin. Microbiol. 46:79-86.
17. Manning, S. E., et al. 2005. Invasive group A streptococcal infection in high school football players, New York City, 2003. Emerg. Infect. Dis. 11:146-149. (Pubitemid 40093372)
18. Martinaud, C., et al. 2009. A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes. Clin. Microbiol. Infect. 16: 292-295.
19. McNeil, S. A., et al. 2005. Safety and immunogenicity of 26-valent group a Streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41:1114-1122. (Pubitemid 41429473)
20. Mihaila-Amrouche, L., A. Bouvet, and J. Loubinoux. 2004. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J. Clin. Microbiol. 42:3844-3846. (Pubitemid 39045727)
21. O'Brien, K. L., et al. 2002. Epidemiology of invasive group a Streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276. (Pubitemid 34800274)
22. O'Loughlin, R. E., et al. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862. (Pubitemid 47580376)
23. Perrocheau, A., et al. 2006. Estimation du nombre total de méningites à pneumocoque de l'enfant par la méthode capture-recapture à 3 sources, France, 2001-2002, p. 16-19. Bulletin epidémiologique hebdomadaire 2-3. Institut de Veille Sanitaire, Saint-Maurice, France. http://www.invs.sante.fr /beh/2006/02-03/beh-02-03-2006. pdf.
24. Raymond, J., L. Schlegel, F. Garnier, and A. Bouvet. 2005. Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis. Infect. Control Hosp. Epidemiol. 26:455-461. (Pubitemid 40695278)
25. Robinson, K. A., et al. 2003. Risk for severe group A streptococcal disease among patients' household contacts. Emerg. Infect. Dis. 9:443-447. (Pubitemid 37070410)
26. Thigpen, M. C., et al. 2007. Nursing home outbreak of invasive group A streptococcal infections caused by 2 distinct strains. Infect. Control Hosp. Epidemiol. 28:68-74. (Pubitemid 46219228)
27. Tyrrell, G. J., M. Lovgren, B. Kress, and K. Grimsrud. 2005. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J. Clin. Microbiol. 43:1678-1683.
28. Varon, E., et al. 1997. Comparison of invasive (septicemic) and non invasive strains of group A streptococci isolated during a one-year national survey in France. The Groupe d'Enquete 1995 sur les Infections Streptococciques. Adv. Exp. Med. Biol. 418:83-85. (Pubitemid 27438383)
29. Vlaminckx, B., et al. 2004. Epidemiological features of invasive and noninvasive group A streptococcal disease in The Netherlands, 1992-1996. Eur. J. Clin. Microbiol. Infect. Dis. 23:434-444. (Pubitemid 38901328)
30. Wahl, R. U., R. Lutticken, S. Stanzel, M. van der Linden, and R. R. Reinert. 2007. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Clin. Microbiol. Infect. 13:1173-1178. (Pubitemid 350056122)
31. Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390-391.